These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 12923179

  • 1. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
    Tofaris GK, Razzaq A, Ghetti B, Lilley KS, Spillantini MG.
    J Biol Chem; 2003 Nov 07; 278(45):44405-11. PubMed ID: 12923179
    [Abstract] [Full Text] [Related]

  • 2. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
    Trimmer PA, Borland MK, Keeney PM, Bennett JP, Parker WD.
    J Neurochem; 2004 Feb 07; 88(4):800-12. PubMed ID: 14756800
    [Abstract] [Full Text] [Related]

  • 3. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ, Kawamata H, Hyman BT.
    Neuroscience; 2001 Feb 07; 104(3):901-12. PubMed ID: 11440819
    [Abstract] [Full Text] [Related]

  • 4. Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies.
    Sharma N, McLean PJ, Kawamata H, Irizarry MC, Hyman BT.
    Acta Neuropathol; 2001 Oct 07; 102(4):329-34. PubMed ID: 11603807
    [Abstract] [Full Text] [Related]

  • 5. alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.
    Tofaris GK, Layfield R, Spillantini MG.
    FEBS Lett; 2001 Nov 30; 509(1):22-6. PubMed ID: 11734199
    [Abstract] [Full Text] [Related]

  • 6. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA.
    J Neurochem; 2004 Jul 30; 90(2):379-91. PubMed ID: 15228595
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions.
    Sawada H, Kohno R, Kihara T, Izumi Y, Sakka N, Ibi M, Nakanishi M, Nakamizo T, Yamakawa K, Shibasaki H, Yamamoto N, Akaike A, Inden M, Kitamura Y, Taniguchi T, Shimohama S.
    J Biol Chem; 2004 Mar 12; 279(11):10710-9. PubMed ID: 14672949
    [Abstract] [Full Text] [Related]

  • 12. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ.
    Science; 2001 Jul 13; 293(5528):263-9. PubMed ID: 11431533
    [Abstract] [Full Text] [Related]

  • 13. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
    Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM.
    Proc Natl Acad Sci U S A; 2003 Feb 18; 100(4):2047-52. PubMed ID: 12576551
    [Abstract] [Full Text] [Related]

  • 14. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
    Braak H, Sandmann-Keil D, Gai W, Braak E.
    Neurosci Lett; 1999 Apr 09; 265(1):67-9. PubMed ID: 10327208
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Uéda K, Ikeda K, Kawai M.
    Brain Res; 1999 Oct 02; 843(1-2):53-61. PubMed ID: 10528110
    [Abstract] [Full Text] [Related]

  • 17. Alpha synuclein in neurodegenerative disorders: murderer or accomplice?
    Mezey E, Dehejia A, Harta G, Papp MI, Polymeropoulos MH, Brownstein MJ.
    Nat Med; 1998 Jul 02; 4(7):755-7. PubMed ID: 9662355
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.
    Gai WP, Yuan HX, Li XQ, Power JT, Blumbergs PC, Jensen PH.
    Exp Neurol; 2000 Dec 02; 166(2):324-33. PubMed ID: 11085897
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.